Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Meregaglia

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Health and Quality of Life Outcomes|September 4, 2017
A systematic literature review of health state utility values in head and neck cancerMichela Meregaglia, John Cairns
Expert Review of Pharmacoeconomics & Outcomes Research|October 10, 2015
Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literatureMichela Meregaglia, John Cairns
Pharmacoeconomics - Open|February 19, 2022
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping AlgorithmsMichela Meregaglia, Rosanna Tarricone
International Journal of Technology Assessment in Health Care|September 28, 2020
The estimation of health state utility values in rare diseases: overview of existing techniquesMichela Meregaglia, Elena Nicod, Michael Drummond
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 6, 2022
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping reviewMichela Meregaglia, Elena Nicod, Michael Drummond
Plos One|April 16, 2015
Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programmeMarcello Tirani, Michela Meregaglia, Alessia Melegaro
Global & Regional Health Technology Assessment|October 9, 2023
Claudio Jommi, Michela Meregaglia, Carmine Pinto
The Patient|January 19, 2021
The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology AssessmentAmanda Whittal, Michela Meregaglia, Elena Nicod
Journal of Crohn'S & Colitis|June 13, 2015
Hospital Burden and Gastrointestinal Surgery in Inflammatory Bowel Disease Patients in Italy: A Retrospective Observational StudyMichela Meregaglia, Helen Banks, Giovanni Fattore
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 27, 2017
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexiaMichela Meregaglia, Ludovica Borsoi, John Cairns, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Health and Quality of Life Outcomes|September 4, 2017
A systematic literature review of health state utility values in head and neck cancerMichela Meregaglia, John Cairns
Expert Review of Pharmacoeconomics & Outcomes Research|October 10, 2015
Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literatureMichela Meregaglia, John Cairns
Pharmacoeconomics - Open|February 19, 2022
Feasibility of Deriving Health State Utilities in Mycosis Fungoides Cutaneous T-Cell Lymphoma Using Mapping AlgorithmsMichela Meregaglia, Rosanna Tarricone
International Journal of Technology Assessment in Health Care|September 28, 2020
The estimation of health state utility values in rare diseases: overview of existing techniquesMichela Meregaglia, Elena Nicod, Michael Drummond
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 6, 2022
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping reviewMichela Meregaglia, Elena Nicod, Michael Drummond
Plos One|April 16, 2015
Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programmeMarcello Tirani, Michela Meregaglia, Alessia Melegaro
Global & Regional Health Technology Assessment|October 9, 2023
Claudio Jommi, Michela Meregaglia, Carmine Pinto
The Patient|January 19, 2021
The Use of Patient-Reported Outcome Measures in Rare Diseases and Implications for Health Technology AssessmentAmanda Whittal, Michela Meregaglia, Elena Nicod
Journal of Crohn'S & Colitis|June 13, 2015
Hospital Burden and Gastrointestinal Surgery in Inflammatory Bowel Disease Patients in Italy: A Retrospective Observational StudyMichela Meregaglia, Helen Banks, Giovanni Fattore
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 27, 2017
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexiaMichela Meregaglia, Ludovica Borsoi, John Cairns, et al.
Pageof 5